Paced by Life Sciences and Diagnostics Business, Danaher Q2 Revenues Increase 5 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Danaher today reported that its revenues for the second quarter increased 5 percent year over year, narrowly missing the consensus analyst estimate on the top line but topping expectations on the bottom line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.